In a filing, Evolent Health Inc revealed its Chief Executive Officer Blackley Seth unloaded Company’s shares for reported $3.74 million on Dec 05 ’23. In the deal valued at $26.54 per share,141,000 shares were sold. As a result of this transaction, Blackley Seth now holds 637,645 shares worth roughly $19.45 million.
Then, McCarthy Daniel Joseph sold 11,000 shares, generating $330,000 in total proceeds. Upon selling the shares at $30.00, the PRESIDENT now owns 198,333 shares.
Before that, Rafferty Emily Ann sold 7,900 shares. Evolent Health Inc shares valued at $221,595 were divested by the Chief Operating Officer at a price of $28.05 per share. As a result of the transaction, Rafferty Emily Ann now holds 70,897 shares, worth roughly $2.16 million.
Oppenheimer initiated its Evolent Health Inc [EVH] rating to an Outperform in a research note published on March 01, 2024; the price target was $45. A number of analysts have revised their coverage, including Barclays’s analysts, who began to cover the stock in early January with a ‘”an Overweight”‘ rating. JMP Securities began covering EVH with “Mkt outperform” recommendation on December 06, 2023. UBS started covering the stock on October 16, 2023. It rated EVH as “a Buy”.
Price Performance Review of EVH
On Monday, Evolent Health Inc [NYSE:EVH] saw its stock jump 0.46% to $30.50. Over the last five days, the stock has lost -4.48%. Evolent Health Inc shares have fallen nearly -7.66% since the year began. Nevertheless, the stocks have fallen -1.13% over the past one year. While a 52-week high of $36.70 was reached on 03/04/24, a 52-week low of $23.33 was recorded on 01/18/24. SMA at 50 days reached $31.86, while 200 days put it at $29.35. A total of 0.73 million shares were traded, compared to the trading of 0.92 million shares in the previous session.
Levels Of Support And Resistance For EVH Stock
The 24-hour chart illustrates a support level at 30.24, which if violated will result in even more drops to 29.98. On the upside, there is a resistance level at 30.76. A further resistance level may holdings at 31.02. The Relative Strength Index (RSI) on the 14-day chart is 38.58, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -1.44, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 76.01%. Stochastics %K at 15.80% indicates the stock is a buying.
How much short interest is there in Evolent Health Inc?
A steep rise in short interest was recorded in Evolent Health Inc stocks on Mar 15, 2024, dropping by -0.51 million shares to a total of 10.81 million shares. Yahoo Finance data shows the prior-month short interest on Feb 15, 2024 was 11.32 million shares. There was a decline of -4.72%, which implies that there is a negative sentiment for the stock. In spite of short shares comprising just 11.13% of the overall stock float, the days-to-cover ratio (short ratio) fell to 9.27.
The most recent change occurred on April 12, 2023 when Stephens began covering the stock and recommended ‘”an Overweight”‘ rating along with a $40 price target.
